BFEC
EDIT icon

Benjamin F. Edwards & Company’s Editas Medicine EDIT Stock Holding History

Benjamin F. Edwards & Company’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,054
Closed -$33K – 1756
2023
Q2 		$33K Hold
4,054
– – ﹤0.01% 1172
2023
Q1 		$29K Buy
4,054
+37
+0.9% +$329 ﹤0.01% 1201
2022
Q4 		$36K Sell
4,017
-53
-1% -$582 ﹤0.01% 1159
2022
Q3 		$50K Sell
4,070
-374
-8% -$5.83K ﹤0.01% 1053
2022
Q2 		$53K Sell
4,444
-2,334
-34% -$31.3K ﹤0.01% 1023
2022
Q1 		$129K Buy
6,778
+2,455
+57% +$45.6K 0.01% 806
2021
Q4 		$115K Buy
4,323
+4,273
+8,546% +$147K 0.01% 848
2021
Q3 		$2K Hold
50
– – ﹤0.01% 1623
2021
Q2 		$3K Hold
50
– – ﹤0.01% 1576
2021
Q1 		$2K Hold
50
– – ﹤0.01% 1613
2020
Q4 		$4K Hold
50
– – ﹤0.01% 1442
2020
Q3 		$1K Hold
50
– – ﹤0.01% 1618
2020
Q2 		$1K Sell
50
-200
-80% -$5.23K ﹤0.01% 1618
2020
Q1 		$5K Hold
250
– – ﹤0.01% 1416
2019
Q4 		$7K Sell
250
-464
-65% -$11.6K ﹤0.01% 1509
2019
Q3 		$16K Sell
714
-1,443
-67% -$35.7K ﹤0.01% 1258
2019
Q2 		$53K Sell
2,157
-583
-21% -$13.9K ﹤0.01% 885
2019
Q1 		$67K Buy
2,740
+297
+12% +$6.72K 0.01% 793
2018
Q4 		$56K Sell
2,443
-950
-28% -$25.9K 0.01% 799
2018
Q3 		$108K Buy
3,393
+300
+10% +$9.69K 0.01% 655
2018
Q2 		$111K Buy
3,093
+65
+2% +$2.3K 0.01% 648
2018
Q1 		$100K Buy
3,028
+205
+7% +$7.3K 0.01% 673
2017
Q4 		$87K Buy
2,823
+2,430
+618% +$61.2K 0.01% 686
2017
Q3 		$9K Hold
393
– – ﹤0.01% 1183
2017
Q2 		$7K Buy
+393
New +$7.08K ﹤0.01% 1176

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Benjamin F. Edwards & Company's EDIT Position: Q3 2023 in Review

Benjamin F. Edwards & Company sold out of Editas Medicine (EDIT) in Q3 2023, closing a stake of 4,054 shares — an estimated $33K sold.

Benjamin F. Edwards & Company first reported a position in EDIT in Q2 2017 and held it in 25 quarters. The position peaked at $129K in Q1 2022. 220 funds tracked by Wall St. Rank hold EDIT as of Q3 2023.

  • Benjamin F. Edwards & Company reported no remaining Editas Medicine position as of Q3 2023 after selling out during the quarter.
  • Benjamin F. Edwards & Company sold 4,054 Editas Medicine shares in Q3 2023, an estimated $33K.
  • Benjamin F. Edwards & Company first reported a position in Editas Medicine in Q2 2017 and held it in 25 quarters.
  • Benjamin F. Edwards & Company's Editas Medicine position peaked at $129K in Q1 2022.
  • 220 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2023.

Based on Benjamin F. Edwards & Company's 13F filing for Q3 2023, filed 13 Nov 2023.